RAFAEL HOLDINGS, INC. Depreciation
RAFAEL HOLDINGS, INC. (RFL) reported Depreciation of $60.00 thousand for the 9-month period ending 2023-04-30, per its 10-Q filed 2023-06-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2023-06-13
- RAFAEL HOLDINGS, INC. depreciation for the quarter ending 2023-04-30 was $19.00K, a 11.76% increase year-over-year.
- RAFAEL HOLDINGS, INC. depreciation for the quarter ending 2022-07-31 was -$53.00K.
- RAFAEL HOLDINGS, INC. depreciation for the quarter ending 2022-04-30 was $17.00K.
- RAFAEL HOLDINGS, INC. depreciation for the quarter ending 2020-07-31 was $1.26M.
- RAFAEL HOLDINGS, INC. depreciation for fiscal 2022 was $1.00K, a 99.96% decline from fiscal 2021.
- RAFAEL HOLDINGS, INC. depreciation for fiscal 2021 was $2.58M, a 2.89% decline from fiscal 2020.
- RAFAEL HOLDINGS, INC. depreciation for fiscal 2020 was $2.66M.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2023-04-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | $60.00K 10-Q · filed 2023-06-13 | ||
| 2023-01-31 | $41.00K 10-Q · filed 2023-03-14 | |||
| 2022-07-31 | -$53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | -$36.00K derived: sum of 2 quarters · filed 2023-06-13 | $1.00K 10-K · filed 2022-10-31 | |
| 2022-04-30 | $17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | $54.00K 10-Q · filed 2023-06-13 | ||
| 2022-01-31 | $37.00K 10-Q · filed 2023-03-14 | |||
| 2021-07-31 | $2.58M 10-K · filed 2021-10-18 | |||
| 2020-07-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-18 | $2.66M 10-K · filed 2021-10-18 | ||
| 2020-04-30 | $1.40M 10-Q · filed 2020-06-09 | |||
| 2019-04-30 | $1.30M 10-Q · filed 2020-06-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |